MetLife Investment Management’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $219K | Buy |
23,927
+3,146
| +15% | +$34.7K | ﹤0.01% | 2374 |
|
|
2026
Q1 | $238K | Sell |
20,781
-467
| -2% | -$6.17K | ﹤0.01% | 2143 |
|
|
2025
Q4 | $322K | Sell |
21,248
-1,413
| -6% | -$21.6K | ﹤0.01% | 2021 |
|
|
2025
Q3 | $332K | Hold |
22,661
| – | – | ﹤0.01% | 2024 |
|
|
2025
Q2 | $253K | Buy |
22,661
+2,327
| +11% | +$28.8K | ﹤0.01% | 2064 |
|
|
2025
Q1 | $332K | Sell |
20,334
-460
| -2% | -$8.07K | ﹤0.01% | 1925 |
|
|
2024
Q4 | $363K | Hold |
20,794
| – | – | ﹤0.01% | 1970 |
|
|
2024
Q3 | $325K | Hold |
20,794
| – | – | ﹤0.01% | 2015 |
|
|
2024
Q2 | $276K | Buy |
20,794
+1,951
| +10% | +$26.7K | ﹤0.01% | 2046 |
|
|
2024
Q1 | $274K | Hold |
18,843
| – | – | ﹤0.01% | 2011 |
|
|
2023
Q4 | $254K | Hold |
18,843
| – | – | ﹤0.01% | 2098 |
|
|
2023
Q3 | $242K | Hold |
18,843
| – | – | ﹤0.01% | 2091 |
|
|
2023
Q2 | $340K | Buy |
18,843
+683
| +4% | +$12.8K | ﹤0.01% | 1944 |
|
|
2023
Q1 | $304K | Buy |
18,160
+6,956
| +62% | +$136K | ﹤0.01% | 1949 |
|
|
2022
Q4 | $230K | Buy |
11,204
+570
| +5% | +$10.1K | ﹤0.01% | 2159 |
|
|
2022
Q3 | $203K | Sell |
10,634
-1,669
| -14% | -$37.5K | ﹤0.01% | 2290 |
|
|
2022
Q2 | $290K | Hold |
12,303
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q1 | $402K | Buy |
12,303
+4,736
| +63% | +$152K | ﹤0.01% | 1910 |
|
|
2021
Q4 | $235K | Hold |
7,567
| – | – | ﹤0.01% | 1958 |
|
|
2021
Q3 | $288K | Hold |
7,567
| – | – | ﹤0.01% | 1846 |
|
|
2021
Q2 | $304K | Hold |
7,567
| – | – | ﹤0.01% | 1879 |
|
|
2021
Q1 | $328K | Hold |
7,567
| – | – | ﹤0.01% | 1761 |
|
|
2020
Q4 | $325K | Sell |
7,567
-2,737
| -27% | -$100K | ﹤0.01% | 1713 |
|
|
2020
Q3 | $321K | Hold |
10,304
| – | – | ﹤0.01% | 1595 |
|
|
2020
Q2 | $330K | Buy |
10,304
+2,744
| +36% | +$91.1K | ﹤0.01% | 1614 |
|
|
2020
Q1 | $212K | Hold |
7,560
| – | – | ﹤0.01% | 1670 |
|
|
2019
Q4 | $349K | Hold |
7,560
| – | – | ﹤0.01% | 1651 |
|
|
2019
Q3 | $401K | Sell |
7,560
-1,822
| -19% | -$94K | ﹤0.01% | 1545 |
|
|
2019
Q2 | $496K | Sell |
9,382
-13,301
| -59% | -$707K | 0.01% | 1486 |
|
|
2019
Q1 | $1.28M | Buy |
22,683
+15,122
| +200% | +$849K | ﹤0.01% | 1521 |
|
|
2018
Q4 | $397K | Hold |
7,561
| – | – | ﹤0.01% | 1511 |
|
|
2018
Q3 | $437K | Hold |
7,561
| – | – | ﹤0.01% | 1614 |
|
|
2018
Q2 | $430K | Hold |
7,561
| – | – | 0.01% | 1496 |
|
|
2018
Q1 | $444K | Hold |
7,561
| – | – | 0.01% | 1438 |
|
|
2017
Q4 | $414K | Buy |
+7,561
| New | +$392K | ﹤0.01% | 1511 |
|
Other funds holding OFIX
ECM
JIC
RCMNY
PCMI
AC
MetLife Investment Management's OFIX Position: Q2 2026 in Review
MetLife Investment Management increased its Orthofix Medical (OFIX) stake by 15% in Q2 2026, buying an estimated $34.7K and bringing the position to 23,927 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #2374.
MetLife Investment Management first reported a position in OFIX in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.28M in Q1 2019. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.
- MetLife Investment Management held 23,927 shares of Orthofix Medical worth $219K as of Q2 2026.
- MetLife Investment Management bought 3,146 Orthofix Medical shares in Q2 2026, an estimated $34.7K.
- Orthofix Medical made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2374 holding.
- MetLife Investment Management first reported a position in Orthofix Medical in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Orthofix Medical position peaked at $1.28M in Q1 2019.
- 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.